Africana55 Radio 
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
ZURICH: Swiss drugs regulator Swissmedic said on Monday it approved Ronapreve, an antibody treatment jointly developed by Roche and Regeneron, to treat Covid-19 patients.
"In this procedure, no data on efficacy against the Omicron variant were submitted," Swissmedic said in a statement.
The antibody treatment was already authorised for prescription in Switzerland under Covid-19 Ordinance 3 since April 15, Swissmedic said.
Read More